met

Documents about met

• Tepotinib in Solid Tumors Harboring MET Alterations#883167ClinicalTrials.gov
• Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects#158170ClinicalTrials.gov
• Management of adverse events associated with MET TKIs in patients with advanced NSCLC: A podcast discussion#684727Figshare
• Middle-Ear Implant With MET V Transducer (Aka MET V System)#811123ClinicalTrials.gov
• RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU)#889546ClinicalTrials.gov
• Aristoteles, Met. XII – eine Theologie?#769512PhilArchive
• When Historiography Met Epistemology#771321PhilArchive
• Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study#14270HAL (France)
• Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer#917893ClinicalTrials.gov
• Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma#828782ClinicalTrials.gov
• Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers#846669ClinicalTrials.gov
• A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor#885761ClinicalTrials.gov
• A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy#894900ClinicalTrials.gov
• Prioriteit voor patienten met een lagere levenskwaliteit#775995PhilArchive
• Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancer#309401OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Charles Ray and the Uncanny at the Met#107326PhilArchive
• DANHEART (H-HeFT and Met-HeFT)#387131ClinicalTrials.gov
• Friedrich Nietzsche's Flirt met Paradoxen en Chaos.#768741PhilArchive
• Office Refurbishment 2026 — MET OFFICE — FMS Interior Services LTD#656272UK Contracts Finder
• A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma#882996ClinicalTrials.gov
• When Moral Responsibility Theory Met My Philosophy of Disability#696859PhilArchive
• Possible Worlds in the Precipice: Why Leibniz Met Spinoza?#775571PhilArchive
• Thurnham Radar- Radome maintenance — Met Office — Raise Telecoms Ltd#608268UK Contracts Finder
• Chenies Radar - Radome maintenance — Met Office — Raise Telecoms Ltd#608272UK Contracts Finder
• Cobbacombe Radar - Radome maintenance — Met Office — Raise Telecoms Ltd#608278UK Contracts Finder
• Predannack Radar - Radome maintenance — Met Office — Raise Telecoms Ltd#608280UK Contracts Finder
• Hameldon Hill Radar - Radome maintenance — Met Office — Raise Telecoms Ltd#608274UK Contracts Finder
• INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme#840374ClinicalTrials.gov
• Effect of HVLA vs MET on Shoulder Mobility and Pain in Adhesive Cpsulitis#880132ClinicalTrials.gov
• Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET#908272ClinicalTrials.gov
• Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy#969146ClinicalTrials.gov
• CANA/Met in Non-diabetic Women With PCOS#160303ClinicalTrials.gov
• Meten met twee maten – vervolg#346391ARPHA OAI-PMH Endpoint
• Social Pedagogy The Al'met'evsk Variant#634200CiNii
• When Paul Met Ludwig: Wittgensteinian Comments on Boghossian’s Antirelativism#746762PhilArchive
• Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated#303739ClinicalTrials.gov
• A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors#832949ClinicalTrials.gov
• Role of heparin-induced HGF release in the acute phase of STEMI#643258HAL (France)
• Diagnosticeren met AI en de aansprakelijkheid van hulpverleners#75223PhilArchive
• Obsessie met de VS leidt af van onze eigen problemen#82617PhilArchive
• Partial eclipse, 20 March 2015: Met Office Unified Model simulations#649316University of Reading Research Data Archive
• Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma#848947ClinicalTrials.gov
• Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)#387121ClinicalTrials.gov
• Filosoof op de arbeidsmarkt: Interview met Babs van den Bergh#759611PhilArchive
• Treating Obese PCOS Patients With LSG vs. Met#201747ClinicalTrials.gov
• Report: TCCON GGG2020 switch to GEOS IT met products#226069CaltechDATA
• Metformin in Assisted Reproduction-MET-AR-study#272317ClinicalTrials.gov
• Bioethics met its COVID‐19 Waterloo: The doctor knows best again#748270PhilArchive
• Velcro lus- en haakzijde met kleeflaag#158970EU Publications
• Velcro lus- en haakzijde met kleeflaag#158985EU Publications